CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NeutroCure aims to develop safe amplifiers of reactive oxygen species (ROS) to treat conditions like cancer and inflammation. By precisely controlling ROS generation, the project seeks to provide new therapeutic options for diseases associated with dysregulated ROS production.
Reactive oxygen species (ROS) have key functions in healthy organism such as redox signaling for regulation of cell growth, triggering formation of neutrophil extracellular traps (NETs), and modulation of inflammation.
Since in high concentration ROS are damaging to tissues, nature has evolved precise mechanisms to control their generation at the required time, concentration and space, proximal to their target.
Disturbance of these mechanisms leads to aberrant ROS production that causes uncontro…
FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBERG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Guildford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Erlangen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY
Ukraine, Lviv
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
